Recent Pathophysiological Aspects of Peyronie’s Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment-Literature Review
Open accessThe DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Peyronie’s disease (PD) is a chronic inflammation of tunica albuginea of the corpora cavernosa that causes an inelastic plaque resulting in penis deformation. Although its etiology is not completely known, there is general consensus that PD is genetically transmitted and secondary to penile trauma. In recent years, numerous studies demonstrated the role played by oxidative stress in PD pathogenesis, and other studies have described successful use of antioxidants in PD treatment. Oxidative stress is an integral part of this disease, influencing its progression. In the early stages of PD, the inflammatory infiltrate cells produce high quantities of free radicals and proinflammatory and profibrotic cytokines, with consequent activation of transcription factor NF- κ B. While conservative therapies commonly used in the early stages of PD include oral substances (Potaba, tamoxifen, colchicine, and vitamin E), intralesional treatment (verapamil, interferon, steroids, and more recently collagenase clostridium histolyticum-Xiaflex), and local physical treatment (iontophoresis, extracorporeal shock wave therapy, and penile extender), the significant results obtained by emerging treatments with the antioxidants cited in this article suggest these therapeutic agents interfere at several levels with the disease’s pathogenetic mechanisms. Antioxidants therapy outcomes are interesting for good clinical practice and also confirm the fundamental role played by oxidative stress in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“PD progresses in two main stages. The first phase typically lasts between 12 and 18 months; this phase is the “active inflammatory phase”, in which plaque forms and progresses to fibrosis and potential calcification, accompanied by pain and worsening of the penile deformity. In the second phase, known as the chronic “stabilized phase”, penile pain decreases and the plaque size and deformity stabil”
From Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases (2024) · cites this paper as [21]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Activated NF-κB has been observed in penile tissues affected by PD, suggesting its involvement in the inflammatory response.”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Current drugs such as collagenase Clostridium histolyticum, exemplified by Xiaflex, is a proteolytic enzyme that selectively targets and breaks down collagen, specifically within fibrous plaques.63,139”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the scientific literature, several articles have appeared in the 21st century that have clarified the important role that “oxidative stress” plays in the pathophysiology of PD [15,16,17,18,19,20,21,22].”
From Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases (2024) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D. S., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,769 · cited 2×
“The chemical process requires molecular oxygen and proceeds via synthesis of an intermediate, N𝜔hydroxyarginine [46].”
BackgroundHealth effects of quercetin: From antioxidant to nutraceutical
Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121 · cited 1×
“It is able to scavenge highly reactive species such as peroxynitrite, hydroxyl radical, superoxide anion, singlet oxygen, and lipid peroxyl radicals [106].”
BackgroundAntioxidant and antiradical activities of l-carnitine
Gülçin, İ. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.05.103 · Cited by 993 · cited 1×
“It is scavenger and neutralizer of superoxide anion, hydrogen peroxide, and peroxynitrite [64].”
BackgroundAntioxidant activity of propolis of various geographic origins
Kumazawa, S., Hamasaka, T., & Nakayama, T. (2004) · Food Chemistry · doi:10.1016/s0308-8146(03)00216-4 · Cited by 946 · cited 1×
“Less than 10mg/g of CAPE is found instead in propolis extracts from Argentina, Bulgaria, Chile, Ukraine, and USA [99].”
BackgroundRecent advances in the chemical composition of propolis
Huang, S., Zhang, C.-P., Wang, K., Li, G., & Hu, F.-L. (2014) · Molecules · doi:10.3390/molecules191219610 · Cited by 765 · cited 1×
“Poplars, and their buds in particular, are considered themain indirect source of propolis in Europe and North America, nontropical Asia, New Zealand, and North Africa (especially the Nile delta) [100].”
BackgroundCarnitine biosynthesis in mammals
Vaz, F. M., & Wanders, R. J. A. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610417 · Cited by 764
Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.
Frei, B., Kim, M. C., & Ames, B. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4879 · Cited by 620 · cited 1×
“In its reduced form, CoQ10 acts as a potent endogenous antioxidant, interacting with oxygen-related radicals, hydrogen peroxide, and singlet oxygen and inhibiting lipid peroxidation (Table 1) [90].”
BackgroundLambert, E., Dassé, E., Haye, B., & Petitfrère, E. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.008 · Cited by 541 · cited 2×
“This typically profibrotic growth factor is mainly produced by fibroblasts and myofibroblasts; it attracts fibroblasts in the area and induces their proliferation, stimulates collagen synthesis, increases synthesis of MMP-1 and MMP-9 (with elastic activity) and TIMP-1, and causes further local fibrin deposit [6, 33, 3…”
BackgroundRaso, G. M., Meli, R., Di Carlo, G., Pacilio, M., & Di Carlo, R. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00999-1 · Cited by 448 · cited 1×
“Moreover quercetin inhibits inflammatory enzymes cyclooxygenase (COX), lipoxygenase (LOX), and iNOS [108].”
BackgroundThe prevalence of Peyronie's disease: results of a large survey
Schwarzer, U., Sommer, F., Klotz, T., Braun, M., Reifenrath, B., & Engelmann, U. (2001) · BJU International · doi:10.1046/j.1464-4096.2001.02436.x · Cited by 440 · cited 1×
“2% and 13%; it generally affects males around 50 years of age, but recently a rise in frequency has been recorded in younger patients [1, 2].”
BackgroundBiological activity of bee propolis in health and disease.
Lotfy, M. (2006) · PubMed · Cited by 437
Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin
Russo, A., Longo, R., & Vanella, A. (2002) · Fitoterapia · doi:10.1016/s0367-326x(02)00187-9 · Cited by 387 · cited 2×
“CAPE exhibits a stronger antioxidant activity than galangin [102].”
BackgroundProposal: Trauma as the Cause of the Peyronie's Lesion
Devine, C. J. J., Somers, K. D., Jordan, G. H., & Schlossberg, S. M. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65361-8 · Cited by 381 · cited 1×
“Although its etiology is not completely known, there is general consensus that PD is genetically transmitted and secondary to penile trauma [4, 5].”
BackgroundBerry Fruits for Cancer Prevention: Current Status and Future Prospects
Seeram, N. P. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf072504n · Cited by 376 · cited 1×
“Although anthocyanins are the most preponderant substances in bilberry, it contains a variety of phenolic compounds, including quercetin, tannins, ellagitannins, and flavonols such as catechin, epicatechin, gallocatechin, and epigallocatechin (the latter two only in unripe fruit), and small quantities of vitamin C [13…”
BackgroundPelletier, J.-P., Jovanovic, D., Fernandes, J. C., Manning, P., Connor, J. R., Currie, M. G., Di Battista, J. A., & Martel-Pelletier, J. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1275::aid-art19>3.0.co;2-t · Cited by 346
Modification of platelet function and arachidonic acid metabolism by bioflavonoids
Landolfi, R., Mower, R. L., & Steiner, M. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90423-4 · Cited by 341
Min, Y.-D., Choi, C.-H., Bark, H., Son, H.-Y., Park, H.-H., Lee, S., Park, J.-W., Park, E.-K., Shin, H.-I., & Kim, S.-H. (2007) · Inflammation Research · doi:10.1007/s00011-007-6172-9 · Cited by 330 · cited 1×
“It inhibits production of TNFα, IL-8, IL-1α, IL-1β, and IL-6 through inhibition of NF-κB activation [107].”
BackgroundSun, C., Wu, Z., Wang, Z., & Zhang, H. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/595393 · Cited by 323 · cited 1×
“For instance, the characteristic compounds of Chinese propolis are caffeic acid, caffeic acid phenethyl ester (CAPE), caffeic acid benzyl ester, 5-methoxy pinobanksin, pinobanksin, pinobanksin-3O-acetate, pinocembrin, chrysin, and galangin [97].”
BackgroundSasaki, K., Hattori, T., Fujisawa, T., Takahashi, K., Inoue, H., & Takigawa, M. (1998) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021955 · Cited by 272
The Chronology of Depression and Distress in Men with Peyronie's Disease
Nelson, C. J., Diblasio, C., Kendirci, M., Hellstrom, W., Guhring, P., & Mulhall, J. P. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00895.x · Cited by 255
Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives
Cho, H. (2004) · Pharmacological Research · doi:10.1016/s1043-6618(03)00248-2 · Cited by 246 · cited 8×
“In addition, TGF-ß1 has the following actions: induces reactive oxygen species (ROS) production; inhibits production of certain matrix metalloproteinases (MMPs), particularly MMP1, MMP-8, and MMP-13, which have collagenolytic activity, increasing synthesis of tissue inhibitors of matrix metalloproteinase (TIMPs, speci…”
BackgroundInfluentialHou, D.-X., Yanagita, T., Uto, T., Masuzaki, S., & Fujii, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.003 · Cited by 231
α-Tocopherol Inhibits the Respiratory Burst in Human Monocytes
Cachia, O., Benna, J. E., Pedruzzi, E., Descomps, B., Gougerot-Pocidalo, M.-A., & Leger, C.-L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32801 · Cited by 230 · cited 1×
“Vitamin E inhibits inflammatory cell ROS release (respiratory burst) [48].”
BackgroundThe Anatomy of the Tunica Albuginea in the Normal Penis and Peyronie's Disease
Brock, G., Hsu, G.-L., Nunes, L., von Heyden, B., & Lue, T. F. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65359-x · Cited by 226 · cited 2×
“Whereas collagen fibers have greater resistance to traction and are inelastic, elastic fibers can be extended up to 150% of their normal length [18].”
BackgroundDiBenedetti, D. B., Nguyen, D., Zografos, L., Ziemiecki, R., & Zhou, X. (2011) · Advances in Urology · doi:10.1155/2011/282503 · Cited by 226 · cited 1×
“2% and 13%; it generally affects males around 50 years of age, but recently a rise in frequency has been recorded in younger patients [1, 2].”
BackgroundRole of Oxidative Stress in the Pathophysiological Mechanism of Erectile Dysfunction
Agarwal, A., Nandipati, K. C., Sharma, R. K., Zippe, C. D., & Raina, R. (2006) · Journal of Andrology · doi:10.2164/jandrol.05136 · Cited by 225 · cited 2×
“Oxidative stress, furthermore, is an important factor in the possible onset of erectile dysfunction in PD, as hyperproduction of superoxide anion and peroxynitrite reduces nitric oxide concentration available for cavernosal muscle relaxation, resulting in long-term endothelial damage; superoxide anion is also reported…”
BackgroundValente, E. G. A., Vernet, D., Ferrini, M. G., Qian, A., Rajfer, J., & Gonzalez-Cadavid, N. F. (2003) · Nitric Oxide · doi:10.1016/j.niox.2003.12.002 · Cited by 223 · cited 3×
“PTX is also a nonspecific phosphodiesterase (PDE) inhibitor and therefore has further antifibrotic activity by reducing iNOS and collagen expression and stimulating fibroblast apoptosis within the tunica albuginea [81, 82].”
BackgroundPENILE TRAUMA: AN ETIOLOGIC FACTOR IN PEYRONIE'S DISEASE AND ERECTILE DYSFUNCTION
Jarow, J. P., & Lowe, F. C. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64222-8 · Cited by 202 · cited 1×
“Although its etiology is not completely known, there is general consensus that PD is genetically transmitted and secondary to penile trauma [4, 5].”
BackgroundSantos, A. C., Uyemura, S. A., Lopes, J. L. C., Bazon, J. N., Mingatto, F. E., & Curti, C. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00003-3 · Cited by 188 · cited 2×
“Pinocembrin possesses a high oxygen radical antioxidant capacity and nitrite scavenging capacity, inhibiting xanthine oxidase activity, which usually induces the generation of superoxide radicals; it also inhibits lipid peroxidation [118, 119].”
BackgroundLong-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases
Jiang, Q., Yin, X., Lill, M. A., Danielson, M. L., Freiser, H., & Huang, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810962106 · Cited by 185
ARMUTCU, F., AKYOL, S., USTUNSOY, S., & TURAN, F. F. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2346 · Cited by 173 · cited 1×
“Moreover, CAPE inhibits iNOS, TNF-α, IL-1β, and IL-6 production [110, 111].”
BackgroundAntifibrotic Role of Inducible Nitric Oxide Synthase
Ferrini, M. G., Vernet, D., Magee, T. R., Shahed, A., Qian, A., Rajfer, J., & Gonzalez-Cadavid, N. F. (2002) · Nitric Oxide · doi:10.1006/niox.2001.0421 · Cited by 167 · cited 1×
“The exact role of iNOS was long unclear, and a number of authors attributed a protective, antifibrotic role to it [39, 145].”
BackgroundThe potential role of honey and its polyphenols in preventing heart disease: a review
Khalil, M., & Sulaiman, S. (2010) · African Journal of Traditional, Complementary and Alternative Medicines · doi:10.4314/ajtcam.v7i4.56693 · Cited by 162 · cited 1×
“It affects lipid peroxidation and helps preserve other antioxidants such as vitamin E and vitamin C [101, 102].”
BackgroundFibrin Deposition in Peyronie's Disease Plaque
Somers, K. D., & Dawson, D. M. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65367-9 · Cited by 160 · cited 14×
“Fibrin accumulation also promotes the influx of fibroblasts, already attracted by TGF-ß1 and PDGF [20, 21].”
BackgroundInfluentialRahman, M., Ichiyanagi, T., Komiyama, T., Hatano, Y., & Konishi, T. (2006) · Free Radical Research · doi:10.1080/10715760600815322 · Cited by 159 · cited 1×
“Due to its high anthocyanin content, bilberry has powerful antioxidant effects against superoxide anion, hydroxyl radical, and peroxynitrite [136].”
Backgroundvan't Hof, R. J., Armour, K. J., Smith, L. M., Armour, K. E., Wei, X. Q., Liew, F. Y., & Ralston, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130511497 · Cited by 158 · cited 2×
“it increases fibroblast production of MMP-1, MMP-2, MMP8, MMP-9, MMP-10, and MMP-13; it promotes synthesis of MMP-9 and MMP-3 and basic fibroblast growth factor; it stimulates production of inducible nitric oxide synthase (iNOS), an enzyme that plays a fundamental role in oxidative stress; it activates NF-κB [6, 12, 1…”
BackgroundWoo, K. J., Jeong, Y.-J., Inoue, H., Park, J.-W., & Kwon, T. K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.12.048 · Cited by 155 · cited 8×
“In addition, TGF-ß1 has the following actions: induces reactive oxygen species (ROS) production; inhibits production of certain matrix metalloproteinases (MMPs), particularly MMP1, MMP-8, and MMP-13, which have collagenolytic activity, increasing synthesis of tissue inhibitors of matrix metalloproteinase (TIMPs, speci…”
BackgroundInfluentialOxidative Stress, Plasminogen Activator Inhibitor 1, and Lung Fibrosis
Liu, R.-M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1903 · Cited by 150
Fibrin Deposition in Peyronie's Disease Plaque
Somers, K. D., & Dawson, D. M. (1997) · The Journal of Urology · doi:10.1097/00005392-199701000-00104 · Cited by 144
Acetyl‐ l ‐carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report
Biagiotti, G., & Cavallini, G. (2001) · BJU International · doi:10.1046/j.1464-410x.2001.02241.x · Cited by 142 · cited 1×
“01); inhibiting disease progression, 92% versus 46% [71].”
Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats
Ahad, A., Ganai, A. A., Mujeeb, M., & Siddiqui, W. A. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.05.007 · Cited by 141 · cited 11×
“Fibrin accumulation also promotes the influx of fibroblasts, already attracted by TGF-ß1 and PDGF [20, 21].”
BackgroundInfluentialClinical presentations of Peyronie's disease
Pryor, J. P., & Ralph, D. J. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900877 · Cited by 139 · cited 1×
“it increases fibroblast production of MMP-1, MMP-2, MMP8, MMP-9, MMP-10, and MMP-13; it promotes synthesis of MMP-9 and MMP-3 and basic fibroblast growth factor; it stimulates production of inducible nitric oxide synthase (iNOS), an enzyme that plays a fundamental role in oxidative stress; it activates NF-κB [6, 12, 1…”
BackgroundAkkus, E., Carrier, S., Baba, K., Hsu, G. ‐., Padma‐Nathan, H., Nunes, L., & Lue, T. F. (1997) · British Journal of Urology · doi:10.1046/j.1464-410x.1997.26511.x · Cited by 131 · cited 1×
“analysis of penile plaques unfailingly detects an alteration and disorganization of collagen associated with a reduction in elastin density [15].”
BackgroundSafarinejad, M. R., Hosseini, S. Y., & Kolahi, A. A. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.05.162 · Cited by 127 · cited 2×
“(2007) observed no significant improvement after treating PD patients with tocopherol compared to placebo treatment [58, 59].”
BackgroundCombination of Penile Traction, Intralesional Verapamil, and Oral Therapies for Peyronie’s Disease
Abern, M. R., Larsen, S., & Levine, L. A. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02519.x · Cited by 121 · cited 1×
“Although PTX was not used exclusively, the study demonstrated that combined treatment without PTT still led to significant penile curvature improvement [85].”
MethodWeidner, W., Schroeder-Printzen, I., Weiske, W.-H., & Vosshenrich, R. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65370-9 · Cited by 121
Roth, S., Spalinger, M. R., Gottier, C., Biedermann, L., Zeitz, J., Lang, S., Weber, A., Rogler, G., & Scharl, M. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154817 · Cited by 106 · cited 1×
“Anthocyanins also reduce the levels of NF-κB, TNFα, and MCP-1, which regulates migration and infiltration of monocytes-macrophages [138].”
BackgroundSasaki, M., Kashima, M., Ito, T., Watanabe, A., Izumiyama, N., Sano, M., Kagaya, M., Shioya, T., & Miura, M. (2000) · Mediators of Inflammation · doi:10.1080/09629350020002895 · Cited by 105
Edwards, D. R., Leco, K. J., Beaudry, P. P., Atadja, P. W., Veillette, C., & Riabowol, K. T. (1996) · Experimental Gerontology · doi:10.1016/0531-5565(95)02010-1 · Cited by 104
The Genetic Basis of Peyronie Disease: A Review
Herati, A. S., & Pastuszak, A. W. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2015.10.002 · Cited by 104
Machado, C. S., Mokochinski, J. B., de Lira, T. O., de Oliveira, F. D. C. E., Cardoso, M. V., Ferreira, R. G., Sawaya, A. C. H. F., Ferreira, A. G., Pessoa, C., Cuesta‐Rubio, O., et al. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/6057650 · Cited by 104 · cited 1×
“Brazilian propolis contains the following: liquiritigenin, daidzein, dalbergin, isoliquiritigenin, formononetin, biochanin A, galangin, kaempferol, pinostrobin, and pinocembrin [98].”
Zhou, L., Wang, K., Li, L., Li, H., & Geng, M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.003 · Cited by 101 · cited 1×
“It inhibits production of TNFα, IL-1β, and IL-6, as well as iNOS and COX-2 expression [120].”
BackgroundSakurai, H., Shigemori, N., Hasegawa, K., & Sugita, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8124 · Cited by 101
Cavallini, G., Biagiotti, G., Koverech, A., & Vitali, G. (2002) · BJU International · doi:10.1046/j.1464-410x.2002.02738.x · Cited by 98
Lee, B., Lin, J.-S., Lin, Y., & Lin, P. (2014) · Nutrition · doi:10.1016/j.nut.2014.10.001 · Cited by 98
Protective effect of apigenin against oxidative stress-induced damage in osteoblastic cells
Jung, W. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1666 · Cited by 98
Dong, Y., Huang, H., Zhao, M., Sun‐Waterhouse, D., Lin, L., & Xiao, C. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.03.021 · Cited by 96 · cited 2×
“Pinocembrin possesses a high oxygen radical antioxidant capacity and nitrite scavenging capacity, inhibiting xanthine oxidase activity, which usually induces the generation of superoxide radicals; it also inhibits lipid peroxidation [118, 119].”
BackgroundIsolation and Characterization of Collagen in Peyronie’s Disease
Somers, K. D., Sismour, E. N., Wright, G. L., Devine, C. J., Gilbert, D. A., & Horton, C. E. (1989) · Journal of Urology · doi:10.1016/s0022-5347(17)40920-7 · Cited by 95 · cited 2×
“, after histological examination of PD plaques, proved an increase in type III collagen content, similarly to what occurs in Dupuytren’s contracture [10, 11].”
BackgroundNakamura, T., Matsushima, M., Hayashi, Y., Shibasaki, M., Imaizumi, K., Hashimoto, N., Shimokata, K., Hasegawa, Y., & Kawabe, T. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0338oc · Cited by 94 · cited 9×
“In addition, TGF-ß1 has the following actions: induces reactive oxygen species (ROS) production; inhibits production of certain matrix metalloproteinases (MMPs), particularly MMP1, MMP-8, and MMP-13, which have collagenolytic activity, increasing synthesis of tissue inhibitors of matrix metalloproteinase (TIMPs, speci…”
BackgroundInfluentialDavila, H. H., Magee, T. R., Vernet, D., Rajfer, J., & Gonzalez-Cadavid, N. F. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.030833 · Cited by 91 · cited 5×
“In addition, TGF-ß1 has the following actions: induces reactive oxygen species (ROS) production; inhibits production of certain matrix metalloproteinases (MMPs), particularly MMP1, MMP-8, and MMP-13, which have collagenolytic activity, increasing synthesis of tissue inhibitors of matrix metalloproteinase (TIMPs, speci…”
BackgroundInfluentialTHE USE OF TOCOPHEROLS IN THE TREATMENT OF PEYRONIE'S DISEASE
Scardino, P. L., & Scott, W. W. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb55300.x · Cited by 91 · cited 1×
“Scardino and Scott (194849) and Steinberg (1951) pioneered the use of vitamin E in medical treatment of PD [56, 57].”
BackgroundJung, Y. C., Kim, M. E., Yoon, J. H., Park, P. R., Youn, H., Lee, H.-W., & Lee, J. S. (2014) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2014.968257 · Cited by 89 · cited 1×
“It inhibits factor NF-κB and reduces production of IL-1β, TNF-α, IL-6, and iNOS [104].”
BackgroundVernet, D., Nolazco, G., Cantini, L., Magee, T. R., Qian, A., Rajfer, J., & Gonzalez-Cadavid, N. F. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.041038 · Cited by 88 · cited 2×
“role in the physiopathological mechanisms of PD [6, 22, 26, 30, 32, 34, 35, 39].”
BackgroundTreatment of Peyronie's disease with oral pentoxifylline
Brant, W. O., Dean, R. C., & Lue, T. F. (2006) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0409 · Cited by 87 · cited 2×
“This study confirmed a peculiarity of PTX already mentioned in previous studies: a capacity to cause almost complete clearance of penile calcifications [83, 84].”
BackgroundResultThe distribution of elastic fibrous elements within the human penis
HSU, G. ‐., BROCK, G., HEYDEN, B. V., NUNES, L., LUE, T. F., & TANAGHO, E. A. (1994) · British Journal of Urology · doi:10.1111/j.1464-410x.1994.tb07645.x · Cited by 85 · cited 1×
“However, in the penile crura and distal part of the corpora cavernosa (apex), the tunica albuginea is only or almost exclusively made up of collagen fibers [18, 19].”
BackgroundGodbout, J. P., Berg, B. M., Krzyszton, C. P., & Johnson, R. W. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.003 · Cited by 84
Gene expression in Peyronie's disease
Gonzalez-Cadavid, N. F., Magee, T. R., Ferrini, M., Qian, A., Vernet, D., & Rajfer, J. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900873 · Cited by 84 · cited 6×
“In the course of PD, the iNOS enzyme is mainly produced by macrophages, smooth muscle cells, andmyofibroblasts [22].”
BackgroundInfluentialA NEW CONCEPT IN THE TREATMENT OF PEYRONIEʼS DISEASE
Scott, W. W., & Scardino, P. L. (1948) · Southern Medical Journal · doi:10.1097/00007611-194802000-00017 · Cited by 84 · cited 3×
“In their 1948 study, after treating 23 patients with tocopherol, Scardino and Scott obtained a plaque size reduction in 91% of cases, curvature improvement in 78% of cases, and resolution of pain in all cases.”
BackgroundInfluentialLazzè, M. C., Pizzala, R., Perucca, P., Cazzalini, O., Savio, M., Forti, L., Vannini, V., & Bianchi, L. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500134 · Cited by 83
Sunil, V. R., Vayas, K. N., Cervelli, J. A., Malaviya, R., Hall, L., Massa, C. B., Gow, A. J., Laskin, J. D., & Laskin, D. L. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.05.009 · Cited by 82 · cited 1×
“They include inhibiting ROS release (respiratory burst) by neutrophils, inhibiting lipid oxidation, and interfering with oxygen-radical-mediated activation of proinflammatory transcription factor NF-κB [74, 75].”
BackgroundShindel, A. W., Lin, G., Ning, H., Banie, L., Huang, Y.-C., Liu, G., Lin, C.-S., & Lue, T. F. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01790.x · Cited by 81 · cited 1×
“published in two articles appearing in the same journal, one shortly after the other, a study divided into two parts, concerning the effects of TGF-ß1 and PTX on cultures of samples of tunica albuginea-derived fibroblasts (TADFs) from men with and without PD; in particular, it focused on the effects on collagen metabo…”
BackgroundAntifibrotic activity of galangin, a novel function evaluated in animal liver fibrosis model
Wang, X., Gong, G., Yang, W.-H., Li, Y., Jiang, M., & Li, L. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.04.004 · Cited by 81 · cited 5×
“One of PD’s numerous profibrotic factors is that it is strongly chemotactic for fibroblasts; it stimulates collagen synthesis; it increases fibroblast production of MMP-1, MMP-2, MMP8, MMP-9, MMP-10, and MMP-13; it promotes synthesis of MMP-9 and MMP-3 and basic fibroblast growth factor; it stimulates production of in…”
BackgroundInfluentialRole of transforming growth factor beta in the pathophysiology of chronic inflammation.
Wahl, S. M., Costa, G. L., Mizel, D. E., Allen, J. B., Skalerič, U., & Mangan, D. F. (1993) · PubMed · Cited by 78
Role of oxidative stress and antioxidants in Peyronie’s disease
Sikka, S. C., & Hellstrom, W. J. G. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900880 · Cited by 77 · cited 6×
“Oxidation is truly triggered at this stage of the disease [30].”
BackgroundInfluentialPentoxifylline treatment and penile calcifications in men with Peyronie's disease
Smith, J. F., Shindel, A. W., Huang, Y.-C., Clavijo, R. I., Flechner, L., Breyer, B. N., Eisenberg, M. L., & Lue, T. F. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2010.117 · Cited by 76 · cited 2×
“This study confirmed a peculiarity of PTX already mentioned in previous studies: a capacity to cause almost complete clearance of penile calcifications [83, 84].”
BackgroundResultUnderstanding the course of Peyronie's disease
Garaffa, G., Trost, L. W., Serefoglu, E. C., Ralph, D., & Hellstrom, W. J. G. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12129 · Cited by 75 · cited 12×
“Fibrin accumulation also promotes the influx of fibroblasts, already attracted by TGF-ß1 and PDGF [20, 21].”
BackgroundInfluentialAlday, E., Valencia, D., Carreño, A. L., Picerno, P., Piccinelli, A. L., Rastrelli, L., Robles‐Zepeda, R. E., Hernández, J., & Velázquez, C. A. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.09.013 · Cited by 73 · cited 1×
“Pinobanksin also has antiproliferative and proapoptotic activity [122].”
BackgroundIntegrins and cadherins as therapeutic targets in fibrosis
Agarwal, S. K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00131 · Cited by 72 · cited 1×
“TGF-ß1 activity includes the following: inducing fibroblasts to produce collagen; influencing ECM deposition, stimulating synthesis of individual components of thematrix, such as proteoglycans and fibronectin; promoting fibroblast proliferation and differentiation into myofibroblasts, that is, mesenchymal cells that s…”
BackgroundDel Carlo, M., Cole, A. A., & Levine, L. A. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.01.093 · Cited by 69
Induratio Penis Plastica (Peyronie's Disease): Clinical Features and Etiology
Byström, J., & Rubio, C. (1976) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365597609179648 · Cited by 67 · cited 1×
“, after histological examination of PD plaques, proved an increase in type III collagen content, similarly to what occurs in Dupuytren’s contracture [10, 11].”
Paulis, G., Brancato, T., D'Ascenzo, R., De Giorgio, G., Nupieri, P., Orsolini, G., & Alvaro, R. (2013) · Andrology · doi:10.1111/j.2047-2927.2012.00007.x · Cited by 67
Self-citationThe pathophysiology of Peyronie’s disease
El-Sakka, A. I., Salabas, E., Dinçer, M., & Kadioglu, A. (2013) · Arab Journal of Urology · doi:10.1016/j.aju.2013.06.006 · Cited by 64 · cited 7×
“TGF-ß1 activity includes the following: inducing fibroblasts to produce collagen; influencing ECM deposition, stimulating synthesis of individual components of thematrix, such as proteoglycans and fibronectin; promoting fibroblast proliferation and differentiation into myofibroblasts, that is, mesenchymal cells that s…”
BackgroundInfluentialJi, Q., Zhang, L., Jia, H., & Xu, J. (2004) · PubMed · Cited by 64
Modulation of human neutrophils' oxidative burst by flavonoids
Ribeiro, D., Freitas, M., Tomé, S. M., Silva, A. M. S., Porto, G., & Fernandes, E. G. R. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.019 · Cited by 63 · cited 13×
“In addition, TGF-ß1 has the following actions: induces reactive oxygen species (ROS) production; inhibits production of certain matrix metalloproteinases (MMPs), particularly MMP1, MMP-8, and MMP-13, which have collagenolytic activity, increasing synthesis of tissue inhibitors of matrix metalloproteinase (TIMPs, speci…”
BackgroundInfluentialApigenin protects against bleomycin-induced lung fibrosis in rats
Chen, L., & Zhao, W. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2885 · Cited by 63 · cited 1×
“It inhibits the expression of TGF-β1 and PDGF, therefore blocking collagen production; apigenin also inhibits differentiation of fibroblasts into myofibroblasts [125].”
BackgroundSafarinejad, M. R. (2010) · International Journal of Impotence Research · doi:10.1038/ijir.2010.20 · Cited by 62
Pathophysiology of Peyronie's disease
Moreland, R. B., & Nehra, A. (2002) · International journal of impotence research · doi:10.1038/sj.ijir.3900875 · Cited by 62
Role of plasma membrane coenzyme Q on the regulation of apoptosis
López‐Lluch, G., Barroso, M. P., Martín, S. F., Fernández‐Ayala, D. J. M., Gómez‐Díaz, C., Villalba, J. M., & Navas, P. (1999) · BioFactors · doi:10.1002/biof.5520090212 · Cited by 61 · cited 1×
“CoQ10 prevents nitrosative stress by inhibition of excess nitric oxide radical production, and it participates in vitamin E and C regeneration [91, 92].”
BackgroundPaulis, G., & Brancato, T. (2012) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152812798889321 · Cited by 60 · cited 4×
“it increases fibroblast production of MMP-1, MMP-2, MMP8, MMP-9, MMP-10, and MMP-13; it promotes synthesis of MMP-9 and MMP-3 and basic fibroblast growth factor; it stimulates production of inducible nitric oxide synthase (iNOS), an enzyme that plays a fundamental role in oxidative stress; it activates NF-κB [6, 12, 1…”
BackgroundInfluentialSelf-citationBentz, M., Zaouter, C., Shi, Q., Fahmi, H., Moldovan, F., Fernandes, J., & Benderdour, M. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24096 · Cited by 57 · cited 1×
“Other authors, instead, proved that iNOS inhibition and peroxynitrite scavenging suppressed evolution of the inflammatory response and the normal course of collagen-induced diseases [146, 147].”
ResultXia, N., Pautz, A., Wollscheid, U., Reifenberg, G., Förstermann, U., & Li, H. (2014) · Molecules · doi:10.3390/molecules19033654 · Cited by 56
Effect of L‐carnitine on the synthesis of nitric oxide in RAW 264·7 murine macrophage cell line
Koç, A., Özkan, T., Karabay, A. Z., Sunguroğlu, A., & Aktan, F. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1807 · Cited by 56 · cited 1×
“It can inhibit factor NF-κB, also suppressing nitric oxide radical production and iNOS protein expression [67].”
BackgroundFreitas, J. P., & Filipe, P. (1995) · Biological Trace Element Research · doi:10.1007/bf02790131 · Cited by 56 · cited 1×
“Furthermore, PTX has been shown to have hydroxyl radical scavenging activity [76].”
BackgroundRacial Distribution of Dupuytrenʼs Disease in Department of Veterans Affairs Patients
Saboeiro, A. P., Pokorny, J. J., Shehadi, S. I., Virgo, K. S., & Johnson, F. E. (2000) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200007000-00013 · Cited by 54 · cited 1×
“LikeDupuytren’s contracture, PD more frequently affects white men, more rarely black, and Asian men [3].”
BackgroundStudy of diversity of anthocyanin composition in bilberry (Vaccinium myrtillus L.) fruits
Burdulis, D., Іванаускас, Л., Dirsė, V., Kazlauskas, S., & Ražukas, A. (2007) · Medicina · doi:10.3390/medicina43120127 · Cited by 52
Coenzyme Q10inhibits mitochondrial complex‐1 down‐regulation and nuclear factor‐kappa B activation
Ebadi, M., Sharma, S. K., Wanpen, S., & Amornpan, A. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00276.x · Cited by 52 · cited 1×
“In addition, CoQ10 decreases gene expression of IL-1β, NF-κB, and iNOS [94].”
BackgroundPeyronie’s disease associated with increase in plasminogen activator inhibitor in fibrotic plaque
Davila, H. H., Magee, T. R., Zuniga, F. I., Rajfer, J., & González-Cadavid, N. F. (2005) · Urology · doi:10.1016/j.urology.2005.01.010 · Cited by 52 · cited 3×
“); it also hinders collagenolysis and inhibits MMPs [39, 40].”
BackgroundBIVALACQUA, T. J., CHAMPION, H. C., LEUNGWATTANAKIJ, S., YANG, D. Y., HYUN, J., ABDEL‐MAGEED, A. B., SIKKA, S. C., KADOWITZ, P. J., & HELLSTROM, W. J. G. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02207.x · Cited by 51 · cited 1×
“Oxidative stress, furthermore, is an important factor in the possible onset of erectile dysfunction in PD, as hyperproduction of superoxide anion and peroxynitrite reduces nitric oxide concentration available for cavernosal muscle relaxation, resulting in long-term endothelial damage; superoxide anion is also reported…”
BackgroundEffects of Carnitine on Thyroid Hormone Action
Benvenga, S., Amato, A., Calvani, M., & Trimarchi, F. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.015 · Cited by 48 · cited 1×
“A randomized study proved that 2 and 4 grams/oral/daily of L-carnitine are capable of reversing hyperthyroidism symptoms [70].”
BackgroundWNT2 Locus is Involved in Genetic Susceptibility of Peyronie’s Disease
Dolmans, G. H., Werker, P. M., de Jong, I. J., Nijman, R. J., Study, L. C., Wijmenga, C., & Ophoff, R. A. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02704.x · Cited by 46 · cited 1×
“Recently, a genetic locus that PD shares with Dupuytren’s contracture was identified; WNT2 is the locus involved in genetic predisposition for both Dupuytren’s disease and PD [9].”
BackgroundJung, H.-J., Park, E.-H., & Lim, C.-J. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.10.0017 · Cited by 46
Gentile, V., Modesti, A., Pera, G. L., Vasaturo, F., Modica, A., Prigiotti, G., Silverio, F. D., & Scarpa, S. (1996) · PubMed · Cited by 45
Lin, G., Shindel, A. W., Banie, L., Ning, H., Huang, Y.-C., Liu, G., Lin, C.-S., & Lue, T. F. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01749.x · Cited by 45 · cited 1×
“published in two articles appearing in the same journal, one shortly after the other, a study divided into two parts, concerning the effects of TGF-ß1 and PTX on cultures of samples of tunica albuginea-derived fibroblasts (TADFs) from men with and without PD; in particular, it focused on the effects on collagen metabo…”
BackgroundFavilla, V., Russo, G. I., Privitera, S., Castelli, T., Madonia, M., La Vignera, S., Condorelli, R., Calogero, A. E., Farina, F. P., Cimino, S., et al. (2014) · Andrologia · doi:10.1111/and.12178 · Cited by 45 · cited 4×
“97), statistically significant results were obtained in group B in regard to orgasmic function (subdomain of 15-question International Index of Erectile Function, IIEF), intercourse satisfaction (subdomain of IIEF), overall satisfaction (subdomain of IIEF), and pain/visual analogue score (VAS) [61].”
BackgroundMethodInfluentialThe paracrine control of vascular motion. A historical perspective
Nava, E., & Llorens, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.003 · Cited by 43 · cited 1×
“NO was also known as endothelium-derived relaxing factor (EDRF), and long-standing widespread prejudice held that EDRF could not be identified with unconventional gaseous molecule NO [45].”
BackgroundZhao, W., Wang, L., Yang, J.-L., Li, L., Xu, W., & Li, T. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1613 · Cited by 41
Jiang, F., Zhang, Z., Zhang, Y., WU, J., Yu, L., & Liu, S. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4639 · Cited by 41 · cited 12×
“It inhibits factor NF-𝜅B and reduces production of IL-1𝛽, TNF-𝛼, IL-6, and iNOS [104].”
BackgroundInfluentialEvaluation of Verapamil Efficacy in Peyronie’S Disease Comparing With Pentoxifylline
Alizadeh, M., Karimi, F., & Fallah, M. R. (2014) · Global Journal of Health Science · doi:10.5539/gjhs.v6n7p23 · Cited by 40 · cited 1×
“Even in this study, PTX appeared effective in treating PD [88].”
BackgroundPaulis, G., Cavallini, G., Giorgio, G., Quattrocchi, S., Brancato, T., & Alvaro, R. (2013) · Inflammation & Allergy-Drug Targets · doi:10.2174/1871528112666131205112432 · Cited by 39 · cited 1×
“The control group (group B) was made up of 41 patients who received no treatment [132].”
MethodSelf-citationPaulis, G., Barletta, D., Turchi, P., Vitarelli, A., Dachille, G., Fabiani, A., & Romano, G. (2015) · Research and Reports in Urology · doi:10.2147/rru.s97194 · Cited by 37
Self-citationVitamin E Inhibits Proliferation of Human Tenon’s Capsule Fibroblasts in vitro
Haas, A. L., Boscoboinik, D. O., Mojon, D. S., Böhnke, M., & Azzi, A. (2009) · Ophthalmic Research · doi:10.1159/000267899 · Cited by 36 · cited 1×
“Vitamin E inhibits TGF-ß1 production; D-alpha-tocopherol and α-tocopherol succinate have been shown to inhibit cellular proliferation of fibroblasts in human pathological fibrosis [49, 50].”
BackgroundRegulation of interleukin 1 generation in immune‐activated fibroblasts
Huleihel, M., Douvdevani, A., Segal, S., & Apte, R. N. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200404 · Cited by 36 · cited 1×
“Proinflammatory cytokine IL-1 is produced by macrophages and fibroblasts [35, 36].”
BackgroundInhibitory effect of vitamin E (α -tocopherol) on spontaneous platelet aggregation in whole blood
Kakishita, E., Suehiro, A., Oura, Y., & Nagai, K. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90233-3 · Cited by 35 · cited 4×
“Furthermore, vitamin E inhibits platelet adhesion and aggregation, improves endothelial function, and can repair DNA [54, 55].”
BackgroundInfluentialHLA Antigens in Peyronie’s Disease
Rompel, R., Mueller-Eckhardt, G., Sehroeder-Printzen, I., & Weidner, W. (1994) · Urologia Internationalis · doi:10.1159/000282566 · Cited by 35
GENTILE, V., MODESTI, A., LA PERA, G., VASATURO, F., MODICA, A., PRIGIOTTI, G., DI SILVERIO, F., & SCARPA, S. (1996) · Journal of Andrology · doi:10.1002/j.1939-4640.1996.tb01757.x · Cited by 35 · cited 10×
“Fibrin accumulation also promotes the influx of fibroblasts, already attracted by TGF-ß1 and PDGF [20, 21].”
BackgroundInfluentialde Sotomayor, M. Á., Bueno, R., Pérez‐Guerrero, C., & Herrera, M. D. (2007) · Journal of Vascular Research · doi:10.1159/000102303 · Cited by 34
Fazzio, A., Marilley, D., & Azzi, A. (1997) · IUBMB Life · doi:10.1080/15216549700201101 · Cited by 34
Mia, M. M., & Bank, R. A. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2285-6 · Cited by 32 · cited 1×
“CAPE attenuates TGF-β-mediated collagen synthesis, inhibits peroxynitrite-augmented TGFβ1 release, counteracts TGF-β-induced differentiation of fibroblasts intomyofibroblasts, and the concurrent formation of collagen; it is capable of partially reversing myofibroblasts into fibroblasts and reversing collagen formation…”
BackgroundRyu, J.-K., Kim, W.-J., Choi, M.-J., Park, J.-M., Song, K.-M., Kwon, M.-H., Das, N.-D., Kwon, K.-D., Batbold, D., Yin, G.-N., et al. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2013.61 · Cited by 32 · cited 1×
“TGF-ß1 activity includes the following: inducing fibroblasts to produce collagen; influencing ECM deposition, stimulating synthesis of individual components of thematrix, such as proteoglycans and fibronectin; promoting fibroblast proliferation and differentiation into myofibroblasts, that is, mesenchymal cells that s…”
BackgroundImplications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease
Bivalacqua, T. J., Champion, H. C., & Hellstrom, W. J. G. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900872 · Cited by 31 · cited 10×
“Induction of an upregulation of iNOS therefore produces high local levels of nitric oxide and a series of its metabolites called reactive nitrogen species (RNS), which are free radicals like ROS but can cause greater cell and tissue damage [34].”
BackgroundInfluentialChen, K., Shi, M., Chien, C., & Shih, Y. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-41 · Cited by 31 · cited 1×
“It inhibits TGF-β and MMP-2 and MMP-9 expression [121].”
BackgroundPlatelet-Derived Growth Factor and Pentoxifylline Modulation of Collagen Synthesis in Myofibroblasts
Isbrucker, R. A., & Peterson, T. C. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8357 · Cited by 29
Anaya, J., & Espinoza, L. R. (1995) · PubMed · Cited by 29
Gouni‐Berthold, I., & Sachinidis, A. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452578 · Cited by 28
Upregulation of mRNA expression of MCP-1 by TGF-β1 in fibroblast cells from Peyronie’s disease
Szardening-Kirchner, C., Konrad, L., Hauck, E. W., Haag, S. M., Eickelberg, O., & Weidner, W. (2008) · World Journal of Urology · doi:10.1007/s00345-008-0320-x · Cited by 27 · cited 2×
“CoQ10 has a strong anti-inflammatory and antifibrotic activity, producing a decrease of proinflammatory cytokines TNF-𝛼, IL-6, TGF-ß1, and monocyte chemoattractant protein-1 (MCP-1), one of the cytokines that regulate migration and infiltration of monocytesmacrophages; furthermore, higher MCP-1 expression was found in…”
BackgroundHu, J. J., Roush, G. C., Berwick, M., Dubin, N. H., Mahabir, S., Chandiramani, M., & Boorstein, R. J. (1996) · PubMed · Cited by 26
Ge, P., Cui, Y., Liu, F., Luan, J. Y., Zhou, X., & Han, J. (2015) · BioScience Trends · doi:10.5582/bst.2015.01000 · Cited by 26 · cited 1×
“L-Carnitine inhibits proliferation and osteoblastic differentiation of fibroblasts [65].”
BackgroundIchiyanagi, T., Hatano, Y., Matsuo, S., & Konishi, T. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.1312 · Cited by 25 · cited 2×
“Induction of an upregulation of iNOS therefore produces high local levels of nitric oxide and a series of its metabolites called reactive nitrogen species (RNS), which are free radicals like ROS but can cause greater cell and tissue damage [34].”
BackgroundLo, H., Wu, M.-W., Pan, S., Peng, C.-Y., Wu, P., & Wu, W. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.011 · Cited by 25 · cited 11×
“Fibrin accumulation also promotes the influx of fibroblasts, already attracted by TGF-ß1 and PDGF [20, 21].”
BackgroundInfluentialChaturvedi, M., Higuchi, M., & Aggarwal, B. B. (1994) · PubMed · Cited by 25
Paulis, G., D’Ascenzo, R., Nupieri, P., De Giorgio, G., Orsolini, G., Brancato, T., & Alvaro, R. (2012) · International Journal of Andrology · doi:10.1111/j.1365-2605.2011.01219.x · Cited by 24
Self-citationCostantini, T. W., Deree, J., Peterson, C. Y., Putnam, J. G., Woon, T., Loomis, W. H., Bansal, V., & Coimbra, R. S. M. (2009) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903183557 · Cited by 24 · cited 1×
“They include inhibiting ROS release (respiratory burst) by neutrophils, inhibiting lipid oxidation, and interfering with oxygen-radical-mediated activation of proinflammatory transcription factor NF-κB [74, 75].”
BackgroundPaulis, G., Cavallini, G., Brancato, T., & Alvaro, R. (2013) · Inflammation & Allergy - Drug Targets · doi:10.2174/1871528111312010009 · Cited by 23
Self-citationTasanarong, A., Kongkham, S., Duangchana, S., Thitiarchakul, S., & Eiam‐Ong, S. (2011) · PubMed · Cited by 22
Paracatu, L. C., de Faria, C. M. Q. G., Quinello, C., Rennó, C., Palmeira, P., Zeraik, M. L., da Fonseca, L. M., & Ximenes, V. F. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/793629 · Cited by 20 · cited 2×
“Moreover, CAPE inhibits iNOS, TNF-α, IL-1β, and IL-6 production [110, 111].”
BackgroundAntiplatelet effect of pentoxifylline in human whole blood
Cruz, J. P. D. L., Romero, M. M., Sanchez, P., & de la Cuesta, F. S. (1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90218-m · Cited by 15 · cited 1×
“PTX inhibits platelet aggregation and improves blood flow by increasing erythrocyte and leukocyte deformability [73].”
BackgroundPeyronie’s disease: A “triple oxygenant therapy”
Ciociola, F., & Colpi, G. M. (2013) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2013.1.36 · Cited by 15 · cited 1×
“In 2013, another report was published about a young PD patient who was treated successfully (significant plaque volume reduction) with a 2year combined therapy (oral PTX/400mg/3 times daily + oral tadalafil/5mg/3 times aweek+ oral L-arginine/2500mg/daily + oral PLC/250mg/daily + oral vitamin B3/20mg/daily + penile ext…”
Background[Clinical evaluation of the use of propoleum in Peyronie's disease].
Lemourt Oliva, M., Filgueiras López, E., Rodríguez Barroso, A., Oramas, E. G., & Ramírez, R. B. (1998) · PubMed · Cited by 15
TOCOPHEROLS IN TREATMENT OF PRIMARY FIBROSITIS
Steinberg, C. L. (1951) · A M A Archives of Surgery · doi:10.1001/archsurg.1951.01250040840013 · Cited by 14
Pharmacological therapy in patients diagnosed with Peyronie's disease.
Halal, A. A., Geavlete, P. A., & Ceban, E. (2012) · PubMed Central · Cited by 11
[Propoleum and Peyronie's disease].
Oliva, M. L., Barroso, A. R., Guillen, M., Guerrero, C. V., Cutiño, M. N., & Monzón, A. F. P. (2003) · PubMed · Cited by 10
[Study of propoleum dosage in Peyronie's disease].
Oliva, M. L., Barroso, A. R., Ramírez, R. B., Oramas, E. G., & Castillo, F. M. (2003) · PubMed · Cited by 8
Oliva, M. L., Valdés, R. F., Ramírez, R. B., Santana, J. L., Oramas, E. G., & Merino, A. (2005) · Archivos Españoles de Urología · doi:10.4321/s0004-06142005000900010 · Cited by 8
Efficacy of pentoxifylline in Peyronie’s disease: Clinical case of a young man
Dell’Atti, L., & Ughi, G. (2014) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2014.3.237 · Cited by 8 · cited 1×
“After oral PTX therapy (400mg/oral/3 times daily) for 6 months, the patient had significant improvement of erectile function and glans tumescence, which made penetration possible [87].”
Method
Research works printed but not linked: 19
- 1989, Journal of Urology, 141, 629
- 2015, Diagnosis and management of peyronie disease, 1, chap 31, 722
- 1993, Journal of Periodontology, 64, 450
- 2007, The clinical implications of basic science research in Peyronies disease, a guide to clinical management, 39
- 1994, Lymphokine and Cytokine Research, 13, 309
- 2011, Journal of the Medical Association of Thailand, 94
- 1996, Cancer Epidemiol Biomarkers Prev, 5, 263
- 1983, Prog Reprod Biol Med, 9, 41
- 2012, Journal of medicine and life, 5, 192
- 2004, Annals of Clinical & Laboratory Science, 4, 427
- 1995, Journal of Rheumatology, 22, 595
- 2006, Asian Pacific Journal of Cancer Prevention, 7, 22
- 1998, Archivos Españoles de Urología, 51, 171
- 2003, Archivos Espanoles de Urologia, 56, 805
- 2003, Archivos Espanoles de Urologia, 56, 814
- 2005, Archivos Espanoles de Urologia, 58, 931
- 2007, Medicina (Kaunas, Lithuania), 43, 971
- 1990, The Main Phenolics of Fruit, 1
- 2007, NUTRAfoods, 6, 13
Cited by
A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie’s disease
Patel, D. P., Christensen, M. B., Hotaling, J. M., & Pastuszak, A. W. (2020) · World Journal of Urology · doi:10.1007/s00345-019-02815-6 · Cited by 64
Mia, M. M., & Bank, R. A. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2285-6 · Cited by 32
Paulis, G., & Berardesca, E. (2019) · Research and Reports in Urology · doi:10.2147/rru.s205184 · Cited by 38
Self-citationMolecular Mechanisms and Current Pharmacotherapy of Peyronie’s Disease: A Review
Zhang, F., Qin, F., & Yuan, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643641 · Cited by 29
“Although the mechanisms of PD are not fully understood several molecular pathological changes of the PD plaque have been recognized recently (Graziottin, 2015; Paulis et al., 2017).”
BackgroundGelbard, M. K., & Rosenbloom, J. (2021) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.195 · Cited by 24
Metadata
- Authors
- Paulis, G., Romano, G., Paulis, L., & Barletta, D.
- Affiliations
- Ospedale Regina Apostolorum (IT)
- Italian League against Cancer, Department of Urologic Oncology, Section of Avellino, Avellino, Italy
- Sapienza University of Rome (IT)
- Policlinico San Matteo Fondazione (IT)
- Corresponding author
- Paulis, Gianni
- ORCID
- Paulis, Gianni
- Venue
- Advances in Urology
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-17
- ISSN
- 1687-6369 (ISSN-L)
- 1687-6377
- PMC
- PMC5514334
- OpenAlex
- W2730490361
- Cited by
- 44
- References
- 144
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 8 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 2
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Advances in Urology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- Peyronie's disease, oxidative stress, free radicals, antioxidants, tunica albuginea, penile plaque, NF-κB, inflammatory cytokines, collagenase clostridium histolyticum, intralesional therapy, extracorporeal shock wave therapy, iontophoresis, tamoxifen, colchicine, vitamin E, verapamil, interferon, penile trauma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
